Assignee
SYLUS CO LTD
KR·4 granted patents·1 pending application·6 citations·filing 2019–2022
Top patents by PatentIndex Score
5 records- 0191US11566056B2Peptide and use thereof for treatment of disease of brain and nervous systemSYLUS CO LTD·Filed 2021·Granted Jan 31, 2023·2 cites·6 claims
- 0282US10808018B2Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen speciesSYLUS CO LTD·Filed 2019·Granted Oct 20, 2020·2 cites·7 claims
- 0376US12252523B2Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen speciesSYLUS CO LTD·Filed 2022·Granted Mar 18, 2025·0 cites·7 claims
- 0476US11987608B2Composition for accelerating cell proliferation comprising erythropoietin-derived peptideSYLUS CO LTD·Filed 2019·Granted May 21, 2024·2 cites·10 claims
- 0561US2020407410A1Use of erythropoietin-derived peptide through effect on cell damage prevention thereofSYLUS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SYLUS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →